Login
$ONC
$411.29 -$5.25 (1.26%) Live

$ONC SEC Filings

Filed On Filing
13 Nov 2026 SCHEDULE 13G/A
12 Nov 2026 Form 4: Wang Xiaodong, Director

Gave 1,183 shares as a gift

10 Nov 2026 Form 4: Ball Titus B., Principal Accounting Officer

Received 1,559 shares by exercise or conversion ($291K) · Sold 1,559 shares ($632K)

09 Nov 2026 Form 4: Lee Chan Henry, SVP, General Counsel

Sold 1,115 shares ($447K)

06 Nov 2026 144
05 Nov 2026 144
05 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition

SAN CARLOS, Calif. – November 5, 2026 – BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and corporate updates from the third quarter of 2026.

29 Oct 2026 Form 4: Wang Xiaodong, Director

Received 31,028 shares by exercise or conversion ($1.14M) · Sold 31,028 shares ($11.3M)

15 Oct 2026 Form 4: Wang Xiaodong, Director

Received 31,027 shares by exercise or conversion ($1.14M) · Sold 31,027 shares ($10.9M)

02 Oct 2026 Form 4: Lee Chan Henry, SVP, General Counsel

Sold 1,115 shares ($418K)

30 Sep 2026 Form 4: Wang Xiaodong, Director

Received 31,028 shares by exercise or conversion ($1.14M) · Sold 31,028 shares ($11.3M)

30 Sep 2026 144
16 Sep 2026 SCHEDULE 13D/A
16 Sep 2026 Form 4: Baker Bros. Advisors Lp, Director and 5 others

Received 61,536 shares by exercise or conversion ($2.27M)

10 Sep 2026 Form 4: Wang Xiaodong, Director

Sold 38,287 shares ($13.4M) · Received 31,027 shares by exercise or conversion ($1.14M)

08 Sep 2026 144
03 Sep 2026 Form 4: Ball Titus B., Principal Accounting Officer

Sold 132 shares ($47K)

01 Sep 2026 144
27 Aug 2026 Form 4: Wu Xiaobin, President and COO

Sold 280 shares ($106K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support